BUZZ-摩根士丹利将 Doximity 的评级上调至 "增持 "后，该公司股价上涨

路透中文

Dec 16

BUZZ-<a href="https://laohu8.com/S/MS">摩根士丹利</a>将 Doximity 的评级上调至 "增持 "后，该公司股价上涨

12月15日 - ** 远程医疗公司Doximity DOCS.N股价上涨3.5%，报45.37美元

** 摩根士丹利将其评级从 "等权重 "上调至 "增持"；将目标价从62美元上调至65美元

** 券商称，对直接面向消费者的药品广告更严格的限制可能会促使制药公司在Doximity等面向医疗保健专业人士的平台上投入更多资金，从而为其预期带来潜在上行空间

** 认为在人工智能工作流程工具的帮助下，医疗保健专业人员市场不断扩大，并认为对OpenEvidence竞争风险的担忧是多余的

** 还补充道，DOCS不断扩大工具套件，深化与临床医生日常工作流程的整合，从而提高了参与度和货币化水平。

** 22家券商中有13家对该股的评级为 "买入 "或更高，7家为 "持有"，2家为 "卖出"；其PT中值为65美元--数据由LSEG编制

** 截至上次收盘，该股今年累计下跌约 18

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2591664626"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2591664626\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2591664626?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-12-16 02:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2591664626","market":"us","top_or_hot":-1,"title":"BUZZ-摩根士丹利将 Doximity 的评级上调至 \"增持 \"后，该公司股价上涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/MS\">摩根士丹利</a>将 Doximity 的评级上调至 \"增持 \"后，该公司股价上涨</title></head><body><p><span>12月15日</span><span> - </span>** 远程医疗公司Doximity <span>DOCS.N</span>股价上涨3.5%，报45.37美元</p><p>** 摩根士丹利将其评级从 \"等权重 \"上调至 \"增持\"；将目标价从62美元上调至65美元</p><p>** 券商称，对直接面向消费者的药品广告更严格的限制可能会促使制药公司在Doximity等面向医疗保健专业人士的平台上投入更多资金，从而为其预期带来潜在上行空间</p><p>** 认为在人工智能工作流程工具的帮助下，医疗保健专业人员市场不断扩大，并认为对OpenEvidence竞争风险的担忧是多余的</p><p>** 还补充道，DOCS不断扩大工具套件，深化与临床医生日常工作流程的整合，从而提高了参与度和货币化水平。</p><p>** 22家券商中有13家对该股的评级为 \"买入 \"或更高，7家为 \"持有\"，2家为 \"卖出\"；其PT中值为65美元--数据由LSEG编制</p><p>** 截至上次收盘，该股今年累计下跌约 18</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-摩根士丹利将 Doximity 的评级上调至 \"增持 \"后，该公司股价上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-摩根士丹利将 Doximity 的评级上调至 \"增持 \"后，该公司股价上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2025-12-16 02:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/MS\">摩根士丹利</a>将 Doximity 的评级上调至 \"增持 \"后，该公司股价上涨</title></head><body><p><span>12月15日</span><span> - </span>** 远程医疗公司Doximity <span>DOCS.N</span>股价上涨3.5%，报45.37美元</p><p>** 摩根士丹利将其评级从 \"等权重 \"上调至 \"增持\"；将目标价从62美元上调至65美元</p><p>** 券商称，对直接面向消费者的药品广告更严格的限制可能会促使制药公司在Doximity等面向医疗保健专业人士的平台上投入更多资金，从而为其预期带来潜在上行空间</p><p>** 认为在人工智能工作流程工具的帮助下，医疗保健专业人员市场不断扩大，并认为对OpenEvidence竞争风险的担忧是多余的</p><p>** 还补充道，DOCS不断扩大工具套件，深化与临床医生日常工作流程的整合，从而提高了参与度和货币化水平。</p><p>** 22家券商中有13家对该股的评级为 \"买入 \"或更高，7家为 \"持有\"，2家为 \"卖出\"；其PT中值为65美元--数据由LSEG编制</p><p>** 截至上次收盘，该股今年累计下跌约 18</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL4T3XL1CB:1","article_id":"2591664626","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2591664626","pubTimestamp":1765823749,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4167":"医疗保健技术","DOCS":"Doximity, Inc.","BK4551":"寇图资本持仓","BK4588":"碎股","BK4539":"次新股","BK4613":"AI应用软件","BK4585":"ETF&股票定投概念"},"translate_title":"BUZZ-Doximity stock rises after Morgan Stanley upgrades it to \"overweight\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DOCS":0.9},"content_text":"BUZZ-摩根士丹利将 Doximity 的评级上调至 \"增持 \"后，该公司股价上涨12月15日 - ** 远程医疗公司Doximity DOCS.N股价上涨3.5%，报45.37美元** 摩根士丹利将其评级从 \"等权重 \"上调至 \"增持\"；将目标价从62美元上调至65美元** 券商称，对直接面向消费者的药品广告更严格的限制可能会促使制药公司在Doximity等面向医疗保健专业人士的平台上投入更多资金，从而为其预期带来潜在上行空间** 认为在人工智能工作流程工具的帮助下，医疗保健专业人员市场不断扩大，并认为对OpenEvidence竞争风险的担忧是多余的** 还补充道，DOCS不断扩大工具套件，深化与临床医生日常工作流程的整合，从而提高了参与度和货币化水平。** 22家券商中有13家对该股的评级为 \"买入 \"或更高，7家为 \"持有\"，2家为 \"卖出\"；其PT中值为65美元--数据由LSEG编制** 截至上次收盘，该股今年累计下跌约 18(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}